Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Stopped As of November 2013, the security situation in rural Northern Mozambique is no longer suitable for this clinical trial.

Conditions

• Trachoma
• Lymphatic Filariasis

Interventions

• DRUG: azithromycin
• DRUG: ivermectin
• DRUG: albendazole
• DRUG: placebo

Sponsor

Emory University